Immunology
Latest Content
AstraZeneca’s Speke U-turn deals blow to Government’s life sciences ambition
AstraZeneca’s shock reversal of its plans to expand vaccine manufacturing at its Speke plant on Merseyside has put an end to hopes of the proposed £450 million investment in the site.
News
AstraZeneca’s Speke U-turn deals blow to Government’s life sciences ambition
AstraZeneca’s shock reversal of its plans to expand vaccine manufacturing at its Speke plant on Merseyside has put an end to hopes of the proposed £450 million investment in the site.
In Depth
E. coli K-12 turns 100 this year
While not your most obvious candidate for centenary celebrations, Brittany Niccum explains why we should commemorate the isolation of E. coli K-12 strain – arguably one of the most thoroughly studied…
Comment And Analysis
Unravelling the secrets of RNA
Advancing scientific knowledge of plant structures not only improves crop yields but also helps treat viruses, explains Yiliang Ding.
Interviews
Diagnosing dysbiosis – understanding imbalance in human gut microbiota
Dysbiosis describes imbalance in healthy gut bacteria... but what is a healthy gut? We ask Christina Casén to explain how such a complex and changeable ecology can be interpreted well enough to diagn…
